Literature DB >> 9402957

Evolutionary origins of two tightly linked mutations in arylsulfatase-A pseudodeficiency.

R Ott1, J S Waye, P L Chang.   

Abstract

Deficient arylsulfatase A activity causes the neurodegenerative disease metachromatic leukodystrophy. However, some individuals with deficient enzyme activity appear clinically normal. This "pseudodeficiency" allele commonly found among many reported populations (frequency approximately 0.10) is associated with two A-->G transitions in cis in the arylsulfatase A gene causing the simultaneous loss of an N-glycosylation and a polyadenylation signal. To understand the evolutionary relationship between such common and tightly linked mutations, we studied 400 individuals in the African, European, Indian and East Asian populations and found none carrying the polyadenylation mutation alone. However, the N-glycosylation mutation could occur independently. Its frequency varied from 0.01 in Indians, 0.06 in Europeans, 0.21 in East Asians to 0.32 in Africans. The frequencies of both mutations occurring together ranged from almost non-existent in the Africans and East Asians, to 0.075 in the Europeans and 0.125 in the Indians. These frequencies were significantly different among populations. Haplotype analysis among homozygous pseudodeficiency individuals and eight multi-generation families with six polymorphic enzymes showed that, of the five haplotypes found in the general population, only one was linked to the double mutations. Alleles among the four populations with only the N-glycosylation mutation also supported linkage to the same haplotype except in some Europeans whose alleles were discordant. These results are consistent with the hypothesis that the N-glycosylation mutation may be a recurrent event among the Europeans but first occurred in an ancestral allele before the emergence of modern Homo sapiens from Africa at approximately 100,000-200,000 years ago. Subsequently, the polyadenylation mutation occurred in this ancient allele with the N-glycosylation mutation, an event that likely took place after the divergence between the European and East Asian lineages.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9402957     DOI: 10.1007/s004390050602

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  4 in total

1.  Extremely low arylsulfatase A enzyme activity does not necessarily cause symptoms: A long-term follow-up and review of the literature.

Authors:  Lucia Laugwitz; Vidiyaah Santhanakumaran; Mareike Spieker; Judith Boehringer; Benjamin Bender; Volkmar Gieselmann; Stefanie Beck-Woedl; Gernot Bruchelt; Klaus Harzer; Ingeborg Kraegeloh-Mann; Samuel Groeschel
Journal:  JIMD Rep       Date:  2022-05-04

2.  Determination of arylsulfatase A pseudodeficiency allele and haplotype frequency in the Tunisian population.

Authors:  Nizar Ben Halim; Imen Dorboz; Rym Kefi; Najla Kharrat; Eleonore Eymard-Pierre; Majdi Nagara; Lilia Romdhane; Nissaf Ben Alaya-Bouafif; Ahmed Rebai; Najoua Miladi; Odile Boespflug-Tanguy; Sonia Abdelhak
Journal:  Neurol Sci       Date:  2015-11-14       Impact factor: 3.307

3.  Arylsulphatase A Pseudodeficiency (ARSA-PD), hypertension and chronic renal disease in Aboriginal Australians.

Authors:  Dave Tang; Michaela Fakiola; Genevieve Syn; Denise Anderson; Heather J Cordell; Elizabeth S H Scaman; Elizabeth Davis; Simon J Miles; Toby McLeay; Sarra E Jamieson; Timo Lassmann; Jenefer M Blackwell
Journal:  Sci Rep       Date:  2018-07-19       Impact factor: 4.379

Review 4.  Developing therapeutic approaches for metachromatic leukodystrophy.

Authors:  Shilpa A Patil; Gustavo H B Maegawa
Journal:  Drug Des Devel Ther       Date:  2013-08-08       Impact factor: 4.162

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.